Literature DB >> 9595020

An acute hemolytic transfusion reaction caused by an anti-P1 that reacted at 37 degrees C.

P A Arndt1, G Garratty, R A Marfoe, G D Zeger.   

Abstract

BACKGROUND: Hemolytic transfusion reactions (HTRs) due to anti-P1 have rarely been reported. There is only one report (from 1945) of an acute HTR due to anti-P1. CASE REPORT: A 74-year-old woman with anti-P1 was given blood that had been found to be compatible by the use of prewarmed serum and saline-suspended red cells (RBCs) and of an antiglobulin test with anti-IgG. The test mixtures were not centrifuged or inspected for agglutination after the 37 degrees C incubation phase. After transfusion of 50 mL of P1 + blood, the patient had an acute HTR (hemoglobinemia, hemoglobinuria, and increased blood pressure, temperature, and respiration).
RESULTS: When studied by a reference laboratory, the anti-P1 was shown to be easily detectable (3+ agglutination) by a prewarming technique (saline or low-ionic-strength saline [LISS]), which included centrifugation at 37 degrees C, but only weak reactions were observed when centrifugation after 37 degrees C incubation was omitted. The indirect antiglobulin test was weakly positive (1+) with anti-IgG, but polyspecific anti-human globulin reacted 2+. The anti-P1 agglutinin was IgM, and its titer was 16 at 37 degrees C (prewarmed) and 256 at 23 degrees C; it caused hemolysis of RBCs at 37 degrees C under conditions known to enhance hemolysis. An indirect monocyte monolayer assay gave results of 11.2 and 22 percent in testing of P1 + RBCs incubated with the patient's serum alone and with patient's serum plus fresh normal serum (as a source of complement), respectively (normal < or = 3%).
CONCLUSION: An acute HTR was caused by a hemolytic anti-P1 that reacted at 37 degrees C. This antibody was not detected by the hospital in a prewarmed crossmatch that omitted 1) the addition of LISS, 2) the reading for agglutination after the 37 degrees C incubation, and 3) the use of antiglobulin sera containing anti-complement.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9595020     DOI: 10.1046/j.1537-2995.1998.38498257376.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia.

Authors:  Zoe Bezirgiannidou; Anna Christoforidou; Eftychia Kontekaki; Athanasios G Anastasiadis; Spyros I Papamichos; Helen Menexidou; Dimitrios Margaritis; Georges Martinis; Elpis Mantadakis
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-18       Impact factor: 2.576

2.  First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.

Authors:  Aseem Kumar Tiwari; Geet Aggarwal; Ravi C Dara; Dinesh Arora; Gautam Kumar Gupta; Vimarsh Raina
Journal:  Asian J Transfus Sci       Date:  2017 Jan-Jun

3.  Acute Hemolytic Transfusion Reaction due to Anti-P1: A Case Report and Review of Institutional Experience.

Authors:  Debra Smith; Thandar Aye; Lay See Er; Theresa Nester; Meghan Delaney
Journal:  Transfus Med Hemother       Date:  2018-10-30       Impact factor: 3.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.